Search

everythinglearnresearchcommunity

for

Search:↓

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Hair loss in postmenopausal woman caused by ovarian issue.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

Higher serum ferritin levels than currently used might be needed to rule out iron deficiency in women with hair loss.

Nearly half of women with PCOS have metabolic syndrome, and lifestyle changes are crucial to prevent complications.

A 33-year-old woman with PCOS and metabolic syndrome was unusually diagnosed with a bone condition called DISH, suggesting a possible link between these conditions.

N-acetylcysteine was more effective and had fewer side effects than metformin for improving insulin resistance in women with PCOS.

Review finds no permanent solution for female hair loss.

Review determines effective, safe treatments for female hair loss.

PCOS is common in young women, especially those aged 21-30, and often involves symptoms like irregular periods, weight gain, and acne.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

The nutritional supplement improved hair density and reduced hair loss in women with female pattern hair loss.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Early treatment helps stop hair loss in women of color.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

The number of advanced breast cancer cases in women under 40 has increased, but the overall numbers are still low.

Testosterone therapy improved symptoms in a woman with congenital adrenal hyperplasia.

Clomiphene testing can help find ovarian causes of high testosterone in postmenopausal women.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Raising awareness about PCOS can improve women's quality of life.

High levels of testosterone and anti-Müllerian hormone before pregnancy are linked to a higher risk of newborns needing intensive care.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Hair loss linked to higher heart disease risk in both men and women.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.